| Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations B Wallace, R Hills, J Rothwell, D Kumar, I Garber, T van Roode, A Larnder, ... Drug Testing and Analysis 13 (4), 734-746, 2021 | 51 | 2021 |
| Metabolism of a hybrid algal galactan by members of the human gut microbiome CS Robb, JK Hobbs, B Pluvinage, G Reintjes, L Klassen, S Monteith, ... Nature chemical biology 18 (5), 501-510, 2022 | 28 | 2022 |
| Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2 KYA Huang, X Chen, A Mohapatra, HTV Nguyen, L Schimanski, TK Tan, ... Nature Communications 14 (1), 311, 2023 | 23 | 2023 |
| Virus-like particles against infectious disease and cancer: guidance for the nano-architect RA Hills, M Howarth Current Opinion in Biotechnology 73, 346-354, 2022 | 21 | 2022 |
| SpySwitch enables pH-or heat-responsive capture and release for plug-and-display nanoassembly SK Vester, R Rahikainen, INA Khairil Anuar, RA Hills, TK Tan, M Howarth Nature Communications 13 (1), 3714, 2022 | 14 | 2022 |
| Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses RA Hills, TK Tan, AA Cohen, JR Keeffe, AH Keeble, ... Nature Nanotechnology, 1-8, 2024 | 10* | 2024 |
Mark HowarthProfessor, Cambridge University在 cam.ac.uk 的电子邮件经过验证
